The Conference on Liver Disease in Africa (COLDA) 2024 took place in Cairo, Egypt from September 19 to 21. This significant event in the field of global liver disease research and prevention brought together leading experts, scholars, and representatives from medical enterprises worldwide to discuss the latest research findings, treatment strategies, and prevention measures for hepatitis diseases.

The prevention and control of hepatitis diseases have always been urgent global health concerns, particularly in Africa, where limited resources and lack of awareness contribute to a severe situation. During the conference, InTec showcased a range of hepatitis products and engaged in discussions with experts and scholars from around the world, offering Chinese expertise and support to hepatitis prevention and control efforts in Africa and beyond.

Distinguished by its high quality, cost-effectiveness, and efficiency, InTec's hepatitis rapid test series cater perfectly to the specific needs of the African region. These products provide robust support for expanding hepatitis screening programs and improving early diagnosis rates. In fact, by achieving simultaneous certification from the World Health Organization (WHO) PQ for HCV and HIV rapid tests in 2019, our products have been instrumental in benefiting numerous patients worldwide.